Predictors of Survival in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy, Surgery, and Radiotherapy

被引：0
|
作者：
Shao, S. [1 ]
Shi, W. [2 ,3 ,4 ]
Zhang, L. [1 ]
Meng, J. [2 ,3 ,4 ]
Guo, X. M. [2 ,3 ]
Yu, X. [2 ,3 ,4 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
[2] Fudan Univ, Shanghai Canc Ctr, Dept Radiat, Shanghai, Peoples R China
[3] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China
[4] Shanghai Clin Res Ctr Radiat Oncol, Shanghai, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 120卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2729
引用
收藏
页码：E333 / E333
页数：1
相关论文
共 50 条
  • [31] BRCAness as a prognostic marker in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: A multicenter retrospective study
    Kosaka, Y.
    Yamamoto, Y.
    Nishimiya, H.
    Ibusuki-Yamamoto, M.
    Hirota, Y.
    Tanino, H.
    Iwase, H.
    Nakamura, S.
    Akashi-Tanaka, S.
    CANCER RESEARCH, 2019, 79 (04)
  • [32] Survival outcomes of dose dense neoadjuvant and adjuvant chemotherapy in triple-negative breast cancer patients: Indian scenario
    Sood, T.
    Rauthan, A.
    Patil, P.
    Kulkarni, S.
    Somashekhar, S. P.
    Zaveri, S.
    Ahuja, V.
    Ashwin, K. R.
    ANNALS OF ONCOLOGY, 2018, 29 : 75 - 75
  • [33] Development and validation of a nomogram for predicting rapid relapse in triple-negative breast cancer patients treated with neoadjuvant chemotherapy
    Ma, Tao
    Liu, Xin-Yu
    Cai, Shuang-Long
    Zhang, Jin
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12
  • [34] Relationship between Complete Pathologic Response to Neoadjuvant Chemotherapy and Survival in Triple-Negative Breast Cancer
    Hatzis, Christos
    Symmans, W. Fraser
    Zhang, Ya
    Gould, Rebekah E.
    Moulder, Stacy L.
    Hunt, Kelly K.
    Abu-Khalaf, Maysa
    Hofstatter, Erin W.
    Lannin, Donald
    Chagpar, Anees B.
    Pusztai, Lajos
    CLINICAL CANCER RESEARCH, 2016, 22 (01) : 26 - 33
  • [35] A gene signature predicts response to neoadjuvant chemotherapy in triple-negative breast cancer patients
    Zheng, Tianzhi
    Pang, Zhiyuan
    Zhao, Zhao
    BIOSCIENCE REPORTS, 2019, 39
  • [36] Dynamics of ctDNA changes during neoadjuvant chemotherapy in triple-negative breast cancer patients
    Cavallone, Luca
    Adriana, Aguilar-Mahecha
    Aldamry, Mohammed
    Lafleur, Josianne
    Cathy, Lan
    Alirezaie, Najmeh
    Bareke, Eric
    Majewski, Jacek
    Ferrario, Cristiano
    Mihalciou, Catalin
    Roy, Josee-Anne
    Markus, Elisabeth
    Robidoux, Andre
    Pelmus, Manuela
    Aleynikova, Olga
    Discepola, Federico
    Basik, Mark
    CANCER RESEARCH, 2018, 78 (04)
  • [37] Effect of neoadjuvant chemotherapy in patients with triple-negative breast cancer: A meta-analysis
    Tian, Muyou
    Zhong, Yahua
    Zhou, Fuxiang
    Xie, Conghua
    Zhou, Yunfeng
    Liao, Zhengkai
    ONCOLOGY LETTERS, 2015, 9 (06) : 2825 - 2832
  • [38] A brief review of treatment options for neoadjuvant chemotherapy in patients with triple-negative breast cancer
    Tiwari, Akash
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2020, 41 (02) : 247 - 249
  • [39] Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients
    Masuda, Hiroko
    Masuda, Norikazu
    Kodama, Yoshinori
    Ogawa, Masami
    Karita, Michiko
    Yamamura, Jun
    Tsukuda, Kazunori
    Doihara, Hiroyoshi
    Miyoshi, Shinichiro
    Mano, Masayuki
    Nakamori, Shoji
    Tsujinaka, Toshimasa
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (04) : 911 - 917
  • [40] Response and prognosis of taxanes and anthracyclines neoadjuvant chemotherapy in patients with triple-negative breast cancer
    Wu, Jiannan
    Li, Shunrong
    Jia, Weijuan
    Su, Fengxi
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (10) : 1505 - 1510
12345